| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 7e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |